The research team, led by Elnaz Harooni and colleagues at Ahvaz Jundishapur University of Medical Sciences in Iran, focused on a well-established experimental approach: the letrozole-induced PCOS mouse. Letrozole is a nonsteroidal inhibitor of aromatase, the enzyme encoded by the Cyp19a1 gene that converts testosterone into estrogen. By blocking estrogen production, letrozole causes androgens to accumulate in female rodents, producing a cluster of symptoms that closely mirrors human PCOS, including androgen excess, elevated blood glucose, abnormal follicle development, and oxidative stress. The researchers administered letrozole orally at 6 milligrams per kilogram of body weight for 21 consecutive days to adult female NMRI mice, then confirmed the PCOS phenotype through daily vaginal smear cytology, which revealed disrupted and arrested estrous cycles in the treated animals.

Lauric acid is a medium-chain fatty acid that accounts for roughly 45 to 53 percent of coconut oil and is widely credited with many of the oil’s reported health benefits, from improved cognitive function in Alzheimer’s disease to reduced cardiovascular risk. Previous work has shown that lauric acid can lower body weight, improve lipid profiles, and enhance insulin sensitivity, effects that have been linked to activation of the Sirt1/AMPK signaling pathway in the liver. That pathway is central to cellular energy sensing: AMP-activated protein kinase, or AMPK, monitors intracellular energy status and maintains energy homeostasis at both the cellular and whole-body levels, while sirtuin 1, or Sirt1, is an NAD-dependent histone deacetylase involved in glucose and lipid metabolism, oxidative stress regulation, and reproductive function. Notably, Sirt1 expression in the ovary is reduced in both human PCOS patients and animal models, making the Sirt1/AMPK axis an attractive therapeutic target.

In the new experiment, forty mice were divided into four groups of ten: a normal control group, a group receiving lauric acid alone, a PCOS group receiving letrozole followed by vehicle, and a PCOS group treated with lauric acid at 150 milligrams per kilogram per day for 15 days after PCOS induction. The dose was selected on the basis of prior studies demonstrating its efficacy and safety across a wide range. The results were striking in several domains. Lauric acid treatment significantly lowered fasting blood glucose and fasting insulin concentrations in the PCOS mice, and it significantly improved both the HOMA-IR index, a standard measure of insulin resistance, and the QUICKI index, which reflects insulin sensitivity. Given that compensatory hyperinsulinemia drives many PCOS features and increases the risk of cardiovascular disease and type 2 diabetes, this metabolic improvement is clinically meaningful.

The fatty acid also reshaped the hormonal landscape of the treated animals. Letrozole had produced the classic PCOS hormonal signature: elevated luteinizing hormone, an increased LH-to-FSH ratio, and raised testosterone, accompanied by reduced follicle-stimulating hormone, progesterone, and estradiol. Fifteen days of lauric acid administration significantly decreased testosterone, LH, and the LH/FSH ratio while significantly raising estradiol levels. Mechanistically, this appears to involve restoration of the aromatase machinery: lauric acid significantly reversed the letrozole-driven decline in ovarian Cyp19a1 protein expression, the very enzyme the drug inhibits, while simultaneously reducing the elevated expression of ovarian androgen receptors that had heightened the animals’ sensitivity to accumulated androgens. Progesterone levels, however, remained depressed despite treatment, a limitation the authors openly acknowledge.

Lipid metabolism responded robustly as well. PCOS mice showed markedly elevated triglycerides and LDL cholesterol alongside reduced HDL cholesterol, a dyslipidemic pattern that mirrors the cardiovascular risk profile of human patients. Lauric acid treatment significantly increased HDL cholesterol and reduced both LDL cholesterol and triglycerides, and it significantly lowered the atherogenic index, a logarithmic marker of cardiometabolic risk calculated from the triglyceride-to-HDL ratio. Interestingly, lauric acid improved this index even in healthy mice, suggesting the fatty acid may beneficially modulate lipid handling independent of disease state. Consistent with these findings, the expression of two key adipose tissue regulators, adiponectin and peroxisome proliferator-activated receptor gamma, or PPARγ, was sharply reduced in the white adipose tissue of PCOS mice and significantly restored by lauric acid treatment. These molecules cooperate in regulating glucose and lipid homeostasis, and their upregulation may partially explain the observed improvements in insulin sensitivity.

The study also probed the oxidative and structural consequences of the disease. Ovaries from PCOS mice contained significantly higher concentrations of malondialdehyde, a lipid peroxidation product, and significantly lower total antioxidant capacity, reflecting the oxidant-antioxidant imbalance known to impair oocyte maturation, ovulation, and fertilization. Lauric acid treatment shifted both markers back toward normal. Histological examination told a parallel story: letrozole produced large ovarian cysts and drastically reduced the number of healthy and antral follicles, whereas lauric acid-treated mice showed fewer cystic follicles and a significant recovery of antral follicle formation, indicating a partial resumption of follicular development. Western blot analysis provided the molecular capstone, revealing that lauric acid significantly restored the letrozole-suppressed expression of Sirt1 and AMPK proteins within ovarian tissue.

The authors propose that these molecular changes form a coherent mechanism. Sirt1 is known to regulate aromatase expression in granulosa cells and to protect both pancreatic beta cells and ovarian granulosa cells through antioxidant and anti-inflammatory actions, while the Sirt1/AMPK pathway has been directly implicated in the insulin resistance of PCOS. The restoration of GLP-1, a gut-derived incretin hormone that fell significantly in PCOS mice and rebounded with lauric acid treatment, adds another layer, since GLP-1 receptor agonists are increasingly used to manage PCOS and have been linked to enhanced adiponectin and PPARγ activity. Not every parameter responded, however. Body weight gain induced by letrozole was not reversed, spexin, another metabolic hormone, remained unchanged, and the improvement in estrous cyclicity, though notable, with 60 percent of treated mice showing normal cycles versus 30 percent of untreated PCOS mice, did not reach statistical significance.

As the authors emphasize, this is the first study to evaluate lauric acid in a letrozole-induced PCOS model, and the findings should be interpreted as preliminary. The work was conducted in mice over a short treatment window, and the improvements, while broad, were partial and inconsistent across all measured endpoints. Translating a 150 milligram per kilogram daily dose into a safe and effective human regimen would require extensive dose-ranging, pharmacokinetic, and safety studies, and the relationship between dietary coconut oil consumption and purified lauric acid supplementation is far from straightforward. Nevertheless, the convergence of evidence, improved insulin sensitivity, corrected dyslipidemia, partially restored sex hormones, reduced oxidative stress, healthier ovarian histology, and reactivated Sirt1/AMPK signaling, positions lauric acid as a compelling candidate for further investigation as a complementary agent against the metabolic and endocrine disturbances of PCOS. Larger and longer studies will be needed to confirm whether this humble coconut-derived fatty acid can truly deliver on that promise.

Subject of Research: Effects of lauric acid on endocrine and metabolic alterations in a letrozole-induced mouse model of polycystic ovary syndrome

Article Title: Lauric acid ameliorates endocrine-metabolic alterations in letrozole-induced polycystic ovary syndrome in female mice

Article References: Harooni, E., Ahangarpour, A., Khorsandi, L., & Mard, S. A. (2026). Lauric acid ameliorates endocrine-metabolic alterations in letrozole-induced polycystic ovary syndrome in female mice. Heliyon, 12(15), Article e45556. https://doi.org/10.1016/j.heliyon.2026.e45556

Image Credits: AI Generated

DOI: 10.1016/j.heliyon.2026.e45556

Keywords: PCOS, lauric acid, coconut oil, Sirt1, AMPK, insulin resistance, letrozole, hyperandrogenism, adiponectin, PPAR gamma, oxidative stress, mouse model

The scale of the stakes is enormous. Food production occupies roughly 40 percent of all habitable land on Earth, drives about 80 percent of deforestation, and accounts for some 70 percent of terrestrial biodiversity loss. Livestock production sits at the center of this crisis, consuming one-third of the global cereal harvest, requiring about 40 percent of global arable land, and claiming all of the world’s pastures. Cattle production is particularly damaging because it combines direct on-farm emissions from enteric fermentation and manure with indirect emissions from feed production and land-use change. At the same time, the food system contributes roughly a third of total global greenhouse gas emissions, and climate change in turn accelerates biodiversity loss by altering habitats, disrupting migration patterns, and intensifying extreme weather events.

Previous life cycle assessments have generally concluded that meat analogues outperform beef across environmental indicators, but most of those studies relied on fixed or simplified supply chains and global-average environmental intensity data. That approach overlooks a crucial reality: the same ingredient can carry wildly different biodiversity consequences depending on the country and ecosystem it comes from. The new study addresses this gap by combining environmentally extended multi-regional input-output models with the GLAM life cycle impact assessment framework, which provides spatially and taxonomically explicit characterization factors for both land use and climate change. The GLAM land-use factors jointly account for land-use intensity and habitat fragmentation within a species-habitat relationship framework, while its climate factors model pixel-based temperature niche limits for individual species.

The technical machinery behind the analysis is considerable. The team employed a tiered hybrid model called FABEXIO, which integrates the Food and Agriculture Biomass Input-Output database, covering 191 countries and 123 food commodities, with EXIOBASE to capture non-biomass inputs such as fuels, fertilizers, and energy that conventional biomass models miss. The functional unit was a single raw burger patty of 113 grams, with recipes drawn from earlier experimental work on meat substitutes. Four alternatives were compared against beef: patties based on pea protein, soy protein, mealworm insects, and mycoprotein, a fungal protein grown on sugar-beet molasses. The ten consuming countries, Belgium, the Czech Republic, France, Germany, Greece, Italy, the Netherlands, Poland, Romania, and Spain, jointly represent about 80 percent of EU beef consumption and 82 percent of the associated biodiversity impacts.

The headline result is that land occupation dominates terrestrial biodiversity impacts, accounting for more than 96 percent of the total across all patty types and all countries, with climate change contributing less than 4 percent. This finding aligns with the IPBES global assessment, which identifies land-use change as the leading cause of terrestrial biodiversity loss, but it contradicts earlier life cycle studies that had identified climate change as the dominant driver using older impact assessment methods. Beef patties generally showed the highest land-driven biodiversity impacts, driven jointly by pastures and cropland, with pastures dominating in Spain, Greece, and Italy. On climate-driven impacts, beef also ranked highest everywhere, primarily due to methane emissions from the cattle themselves.

But the most surprising result concerns the pea patty. In Belgium, the Czech Republic, Germany, and Poland, the pea-based burger actually exceeded beef in terrestrial biodiversity impact. The culprit is coconut oil. Although it makes up only 5.7 grams of a pea patty, coconut oil sourced largely from the Philippines, Indonesia, and Vanuatu dominates the biodiversity impacts of pea and mycoprotein patties, contributing roughly 75 percent and 58 percent of their totals respectively. Tropical ecosystems carry extremely high biodiversity sensitivity in the GLAM framework because of high global extinction probabilities, small ecoregion sizes, and fragmented land-use patterns, with cropland characterization factors in the Philippines and Indonesia reaching up to 2.2 times ten to the minus fourteen PDF per square meter. By contrast, beef supply chains in the countries where pea patties performed worst are highly diversified, relying primarily on domestic production with modest imports from Australia, India, and Italy, all of which have comparatively low biodiversity sensitivity.

The decoupling between land-use footprints and biodiversity impacts is one of the study’s most consequential insights. Pea protein, the main ingredient at 20 grams per patty, dominates the pea patty’s land-use footprint at about 46 percent but contributes only around 14 percent of its biodiversity impact, because it is sourced mostly within the EU. Similarly, molasses, the main substrate for mycoprotein patties at 339 grams per patty, accounts for roughly 40 percent of the land footprint but only about 23 percent of biodiversity impacts on average. Conventional mass-based life cycle assessment methods, and land-use footprints more broadly, systematically fail to capture these spatial differences in biodiversity sensitivity, meaning high-impact, low-mass ingredients like coconut oil can slip through the environmental accounting unnoticed.

Not all alternatives fared badly. Soy patties consistently delivered the lowest biodiversity impacts across all ten countries, with their impacts driven mainly by soy protein and rape oil. Replacing beef patties with soy patties in food service, assumed to represent about 5 percent of national beef consumption, could reduce land-driven biodiversity impacts by 71 to 97 percent per patty, corresponding to an estimated 3.6 to 4.9 percent reduction in national biodiversity loss associated with beef. The largest gains would come in Spain, Greece, and Italy, where beef’s impact is highest at around 96 to 97 percent reduction, while Belgium would see the smallest benefit at 71 percent. Even here, geography matters: rape oil sourced from Australia, with a cropland factor of 9.1 times ten to the minus fifteen PDF per square meter, drove up impacts in Belgium, France, Germany, Italy, and the Netherlands, while domestic sourcing kept impacts lower in the Czech Republic, Poland, and Romania.

The sensitivity analyses tested the robustness of these conclusions against alternative allocation ratios, protein-based and energy-based functional units, and beef patty composition. The best- and worst-performing patties remained largely unchanged under most scenarios, though under an energy-based functional unit soy patties lost their top position in Belgium, Germany, and Poland due to their relatively low energy content of 191 kilocalories per patty. The most dramatic shift came when coconut oil was replaced with rape oil on a mass-equivalent basis: biodiversity impacts fell by approximately 74 percent for pea patties and 62 percent for mycoprotein patties, transforming the rankings. Under that scenario, beef patties consistently exhibited the highest biodiversity impacts across all countries, demonstrating that a single reformulation decision can outweigh the choice of protein source itself.

The authors frame their findings as a warning against biodiversity leakage, the displacement of harmful activities from one region to another through trade and consumption shifts. Local environmental gains in Europe may be offset, or more than offset, by impacts displaced to more biodiversity-sensitive tropical regions. They also caution that avoided biodiversity impact means preventing further habitat occupation, not restoring degraded ecosystems, since spared land can be reoccupied for urban expansion, alternative agriculture, or biofuel production. Their recommendations are concrete: manufacturers should adopt biodiversity-aware sourcing and reformulate away from high-impact ingredients, while policymakers should embed biodiversity metrics into sustainability standards, public procurement, and labelling schemes for alternative-protein products. The message for consumers is nuanced but clear: the plant-based burger is not automatically the biodiversity-friendly choice, and the geography of the supply chain matters as much as the patty on the plate.

Subject of Research: Terrestrial biodiversity impacts of replacing beef patties with alternative-protein burgers across ten EU countries

Article Title: Terrestrial biodiversity impacts of replacing beef with alternative-protein burger patties across ten European Union Countries

Article References: Zhang, Y., Rasul, K., Dorber, M., Stadler, K., Hertwich, E. G., & Verones, F. (2026). Terrestrial biodiversity impacts of replacing beef with alternative-protein burger patties across ten European Union Countries. Journal of Industrial Ecology, 30(4), 1761-1777. https://doi.org/10.1007/s44498-026-00120-1

Image Credits: AI Generated

DOI: 10.1007/s44498-026-00120-1

Keywords: biodiversity, alternative protein, beef, plant-based burgers, life cycle assessment, land use, coconut oil, soy protein, mycoprotein, supply chains, European Union, food system